Open AccessSocial Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials
Author(s) -
Michele P. Andrasik,
Fredericka Albertina Sesay,
Abby Isaacs,
Linda Oseso,
Mary Allen
Publication year - 2020
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0000000000002369
Subject(s) - hiv vaccine , medicine , vaccine trial , clinical trial , pre exposure prophylaxis , vaccination , family medicine , human immunodeficiency virus (hiv) , men who have sex with men , immunology , syphilis
Given the persistent stigma and discrimination against HIV worldwide, preventive HIV vaccine trials face unique challenges. Negative social impacts (NSIs)-problems that HIV vaccine trial participants face in many different spheres of their lives related to trial participation-have received a great deal of attention. Beneficial social impacts (BSIs)-perceived benefits experienced by a participant and resulting from their trial participation-are a critical component of participants' experiences, yet they have received little attention.